Statistical inference for tumor growth inhibition T/C ratio

Journal of Biopharmaceutical Statistics

Volumn 20, Issue 5, 2010, Pages 954-964

  Wu, Jianrong ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Bootstrap; Confidence interval; Hypothesis; Likelihood ratio; Log normal; Sample size; Tumor growth inhibition; Xenografts

Indexed keywords

SCH 717454;

ARTICLE; BOOTSTRAPPING; CANCER INHIBITION; CONFIDENCE INTERVAL; INTERMETHOD COMPARISON; NONHUMAN; NONPARAMETRIC TEST; PRIORITY JOURNAL; SAMPLE SIZE; STATISTICAL ANALYSIS; TUMOR VOLUME; TUMOR XENOGRAFT;

ALGORITHMS; ANIMALS; ANTIBODIES, MONOCLONAL; BIOSTATISTICS; CONFIDENCE INTERVALS; HUMANS; LIKELIHOOD FUNCTIONS; MICE; NEOPLASMS; SAMPLE SIZE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955856354     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543401003618983     Document Type: Article

References (19)

1. Atadja, P., Gao, L., Kwon, P., Trogani, N., Walker, H., Hsu, M., Yeleswarapu, L., Chandramouli, N., Perez, L., Versace, R., Wu, A., Sambucetti, L., Lassota, P., Cohen, D., Bair, K., Wood, A., Remiszewski, S. (2004). Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824. Cancer Res. 64:689-695.
2. Barndorff-Nielsen, O. E. (1991). Modified signed log likelihood ratio. Biometrika 78:557-563.
3. Barndorff-Nielsen, O. E., Cox, D. R. (1994). Inference and Asymptotics. London: Chapman and Hall.
4. Bissery, M. C., Guenard, D., Gueritte-Voegelein, F., Lavelle, F. (1991). Experimental antitumor activity of taxotere (RP 56976, NSC 629503), a taxol analogue. Cancer Res. 51:4845-4852.
5. Corbett, T. H., White, K., Polin, L., Kushner, J., Paluch, J., Shih, C., Grossman, C. S. (2003). Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169. Investig. New Drugs 21:33-45.
6. Cox, D. R., Hinkley, D. V. (1974). Theoretical Statistics. London: Chapman and Hall.
7. Efron, B., Tibshirani, R. J. (1993). An Introduction to the Bootstrap. New York: Chapman and Hall.
8. Fraser, D. A. S., Reid, N., Wu, J. (1999). A simple general formula for tail probabilities for frequentist and Bayesian inference. Biometrika 86:249-264.
9. Heitjan, D. F., Manni, A., Santen, R. J. (1993). Statistical analysis of in vivo tumor growth experiments. Cancer Res. 53:6042-6050.
10. Houghton, P. J., Morton, C. L., Tucker, C., Payne, D., Favours, E., Cole, C., Gorlick, R., Kolb, E. A., Zhang, W., Lock, R., Carol, H., Tajbakhsh, M., Reynolds, C. P., Maris, J. M., Courtright, J., Keir, S. T., Friedman, H. S., Stopford, C., Zeidner, J., Wu, J., Liu, T., Billups, C. A., Khan, J., Ansher, S., Zhang, J., Smith, M. A. (2007). The pediatric preclinical testing program: Description of models and early testing results. Pediatr. Blood Cancer 49:928-940.
11. Hothorn, L. (2006). Statistical analysis of in vivo anticancer experiments: Tumor growth inhibition. Drug Inform. J. 40:229-238.
12. Johnson, J. I., Decker, S., Zaharevitz, D., Rubinstein, L. V., Venditti, J. M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., Sausville, E. A. (2001). Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br. J. Cancer 84:1424-1431.
13. Kolb, E. A., Gorlick, R., Houghton, P. J., Morton, C. L., Lock, R., Carol, H., Reynolds, C. P., Maris, J. M., Keir, S. T., Billups, C. A., Smith, M. A. (2008). Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program. Pediatr. Blood Cancer 50:1190-1197.
14. Tan, M., Fang, H. B., Tian, G. L., Houghton, P. J. (2002). Small-sample inference for incomplete longitudinal data with truncation and censoring in tumor xenograft models. Biometrics 58:612-620.
15. Thompson, J., George, E. O., Poquette, C. A., Cheshire, P. J., Richmond, L. B., de Graaf, S. S., Ma, M., Stewart, C. F., Houghton, P. J. (1999). Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Clin. Cancer Res. 5:3617-3631.
16. van Belle, G., Martin, D. C. (1993). Sample size as a function of coefficient of variation and ratio of means. Biometrics 58:612-620.
17. Vardi, Y., Ying, Z. L., Zhang, C. H. (2001). Two-sample tests for growth curves under dependent right censoring. Biometrika 88:949-960.
18. Voskoglou-Nimikos, T., Pater, J. L., Seymour, L. (2003). Clinical predictive value of the in vitro cell line, human xenograft and mouse allograft preclinical cancer models. Clin. Cancer Res. 9:4227-4239.
19. Wu, J., Jiang, G., Wong, A. C. M., Sun, X. (2002). Likelihood analysis for the ratio of means of two independent log-normal distributions. Biometrics 58:463-469.